LFG
PBYI icon

Larson Financial Group’s Puma Biotechnology PBYI Stock Holding History

Larson Financial Group’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-255
Closed -$3K – 820
2020
Q3 		$3K Buy
+255
New +$2.6K ﹤0.01% 568
2020
Q1 		– Sell
-210
Closed -$2K – 631
2019
Q4 		$2K Hold
210
– – ﹤0.01% 462
2019
Q3 		$2K Buy
210
+130
+163% +$1.4K ﹤0.01% 441
2019
Q2 		$1K Hold
80
– – ﹤0.01% 458
2019
Q1 		$3K Sell
80
-70
-47% -$2.14K ﹤0.01% 355
2018
Q4 		$3K Buy
+150
New +$4.5K ﹤0.01% 330

Other funds holding PBYI

DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Larson Financial Group's PBYI Position: Q4 2020 in Review

Larson Financial Group sold out of Puma Biotechnology (PBYI) in Q4 2020, closing a stake of 255 shares — an estimated $3K sold.

Larson Financial Group first reported a position in PBYI in Q4 2018 and held it in 6 quarters. The position peaked at $3K in Q3 2020. 123 funds tracked by Wall St. Rank hold PBYI as of Q4 2020.

  • Larson Financial Group reported no remaining Puma Biotechnology position as of Q4 2020 after selling out during the quarter.
  • Larson Financial Group sold 255 Puma Biotechnology shares in Q4 2020, an estimated $3K.
  • Larson Financial Group first reported a position in Puma Biotechnology in Q4 2018 and held it in 6 quarters.
  • Larson Financial Group's Puma Biotechnology position peaked at $3K in Q3 2020.
  • 123 funds tracked by Wall St. Rank held Puma Biotechnology as of Q4 2020.

Based on Larson Financial Group's 13F filing for Q4 2020, filed 14 Jan 2021.